Last reviewed · How we verify
Prebiotin
At a glance
| Generic name | Prebiotin |
|---|---|
| Sponsor | University of Maryland, Baltimore |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Prebiotic Treatment in People With Schizophrenia (NA)
- Prebiotic vs Probiotic in Multiple Sclerosis (NA)
- Prebiotics and Diet to Reduce "Leaky" Gut in First Degree Relatives of Crohn's Disease Patients (NA)
- Mercury Metabolism by Bacteria in Humans (NA)
- Prebiotic Treatment in People With Schizophrenia - Pilot Study (PHASE4)
- Study of a Prebiotic Supplement to Mitigate Excessive Weight Gain Among Physicians in Residency (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Prebiotin CI brief — competitive landscape report
- Prebiotin updates RSS · CI watch RSS
- University of Maryland, Baltimore portfolio CI